COMMUNIQUÉS West-GlobeNewswire

Conatus Pharmaceuticals Announces Top-line Results from Phase 2b POLT-HCV-SVR Clinical Trial

04/04/2018 - 22:05

Biopsy-based Proof of Concept in Liver Fibrosis and Cirrhosis Supports Further Evaluation Conference Call and Webcast Presentation at 4:30 p.m. ET Today SAN DIEGO, April 04, 2018 (GLOBE NEWSWIRE) -- Conatus [...]

Immunovaccine Files Circular for Annual and Special Meeting of Shareholders

04/04/2018 - 22:05

NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, April 04, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology [...]

Intercept Pharmaceuticals Announces Proposed $120 Million Public Offering and Concurrent $92 Million Private Placement of Common Stock

04/04/2018 - 22:05

NEW YORK, April 04, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

Paratek’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA

04/04/2018 - 22:01

-- PDUFA Action Date in October 2018 -- BOSTON, April 04, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ) announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug [...]

Collegium to Present at the H.C. Wainwright Global Life Sciences Conference

04/04/2018 - 22:01

CANTON, Mass., April 04, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) today announced that management will present at the H.C. Wainwright Global Life Sciences Conference on Tuesday, April 10, [...]

CRISPR Therapeutics Announces the Appointment of Steve Caffé as Head of Regulatory Affairs

04/04/2018 - 22:01

ZUG, Switzerland and CAMBRIDGE, MA., April 04, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]

Apricus Biosciences Announces Closing of $3.55 Million Public Offering

04/04/2018 - 22:01

SAN DIEGO, April 04, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI ), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the closing of its [...]

Bradmer Announces Fourth Quarter and Full Year 2017 Financial Results

04/04/2018 - 22:00

TORONTO, April 04, 2018 (GLOBE NEWSWIRE) -- Bradmer Pharmaceuticals Inc. (TSX VENTURE:BMR.H) (“Bradmer” or the “Company”) today announced its fourth quarter and full year 2017 financial results. Financial Results [...]

CMS Changes to Medicare Part D Provide Potential Expansion of TRHC Medication Therapy Management Services for Medicare Advantage Plans

04/04/2018 - 21:52

Patient Care vs. Administrative Costs Now the Focus of Part D Health Plan Expenditure Ratios MOORESTOWN, N.J., April 04, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC ), a healthcare [...]

Legacy Good Samaritan Medical Center in Portland Now Offers Non-Invasive HIFU for Prostate Cancer

04/04/2018 - 20:00

HIFU, high intensity focused ultrasound, is an outpatient procedure for killing prostate tissue in patients with localized prostate cancer and has less risk of side effects than surgery or radiation CHARLOTTE, N.C., [...]

Bone Therapeutics SA : Transparency notification received from S.R.I.W. SA and Sofipôle SA

04/04/2018 - 18:01

Regulated information Transparency notification received from S.R.I.W. SA and Sofipôle SA Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings Gosselies, Belgium, 4 April 2018, 6 pm CEST [...]

Bone Therapeutics SA : Notification de transparence reçue de la part de S.R.I.W. SA et Sofipôle SA

04/04/2018 - 18:01

Information réglementée Notification de transparence reçue de la part de S.R.I.W. SA et Sofipôle SA Article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes Gosselies, [...]

Boehringer Ingelheim and OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership to Develop a Pioneering Checkpoint Inhibitor for the Treatment of Advanced Solid Tumors

04/04/2018 - 18:00

Boehringer Ingelheim and OSE Immunotherapeutics enter into a global license and collaboration agreement in immuno-oncology to develop OSE-172, a novel checkpoint inhibitor antibody targeting myeloid lineage cells [...]

Orpea SA: Post Stabilisation Notice

04/04/2018 - 17:58

PUTEAUX, France, April 04, 2018 (GLOBE NEWSWIRE) -- EURONEXT PARIS:ORP HSBC (contact: Syndicate desk, telephone: +44 207 992 8066) hereby gives notice that no stabilisation (within the meaning of the rules of the [...]

Diaxonhit annonce la fusion de ses deux filiales Eurobio et InGen

04/04/2018 - 17:46

Diaxonhit annonce la fusion de ses deux filiales Eurobio et InGen Naissance d'eurobio-ingen, acteur majeur du diagnostic et des sciences de la vie en France Dernière étape de la restructuration du groupe Diaxonhit, en [...]

Dr. George Brett Named Senior Vice President of Consulting for Capstone Performance Systems

04/04/2018 - 17:36

New Organizational Structure to Improve Efficiency, Accommodate Growth ST. LOUIS and MOORESTOWN, N.J., April 04, 2018 (GLOBE NEWSWIRE) -- Capstone Performance Systems, a subsidiary of Tabula Rasa HealthCare, Inc. (“TRHC [...]

Novartis announces JAMA Cardiology publication of data showing Entresto® improves physical and social activity in HFrEF patients versus enalapril

04/04/2018 - 17:00

Post-hoc analysis of PARADIGM-HF published in JAMA Cardiology shows heart failure patients treated with Entresto experience significant improvements in physical and social activities compared to those taking enalapril[1 [...]

C-RAD to supply advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna through Varian Medical Systems

04/04/2018 - 16:30

C-RAD announced today orders from Varian Medical Systems to equip Nya Karolinska Solna (NKS), Sweden with its latest SIGRT (Surface Image Guided Radiation Therapy) solution. The contract includes the supply of C-RAD’s [...]

BioStem Technologies Inc. Enters Into Consulting and Advisory Agreement with Dr. Irmgard Huber

04/04/2018 - 16:28

Pompano Beach, FL, April 04, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a focus in [...]